Roel Sterken joined Biogazelle in June 2019 to strengthen the management team, and has taken the role of CEO since December 2020. Prior to joining Biogazelle, Roel was a Sr. Strategy and Business consultant for Janssen Pharmaceuticals and Investment Manager at DROIA Oncology Ventures, carrying different managerial and board level responsibilities. Roel holds a PhD in Molecular Biotechnology from VIB-Ghent University and an MBA degree from Solvay Brussels School of Economics and Management.
Jan Hellemans is one of the founders of Biogazelle. Jan has a Master's degree in Biotechnology, a PhD in Medical Sciences (Ghent University, Belgium) and over 15 years of experience in human genetics. He acquired extensive experience in next generation sequencing and genetic diagnostics from managing an academic core facility and introducing the corresponding wet and dry lab technology in a clinical diagnostics lab at Ghent University Hospital.
Jo Vandesompele has a Master's degree in Bio-engineering and a PhD in Medical Sciences. As Chief Scientific Officer, he is responsible for the scientific progress in the company. Jo also holds a professorship at Ghent University, studying non-coding RNA biology in cancer and developing nucleic acid quantification strategies. He is co-author of more than 200 peer-reviewed articles, together cited more than 30,000 times.
Martine Goergen joined Biogazelle in November 2020 to strengthen the management team and to lead the quality team. Martine served for 8 years at Multiplicom (part of Agilent Technologies) as Director Quality and for over 25 years at Innogentics ( now Fujirebio) in roles of progressive responsibly. She has more than 20 years of experience in quality assurance and leadership.
Martine holds a Master of Science degree in Biotechnology and is specialized in setting up and improving quality systems.
Friedel Nollet has a master degree in Chemistry and a PhD in Molecular Biology. Friedel joined Biogazelle in October 2020 to lead the COVID-19 testing team. He has 21 years of experience introducing molecular diagnostic testing using PCR, qPCR, Sanger and NGS sequencing in a hospital laboratory. He has extensive expertise in oncology, onco-hematology and HLA typing, is a BELAC ISO15189 technical auditor in these areas, and a guest professor at Howest University College Bruges.
Technologiepark 82
B-9052 Zwijnaarde
Belgium
email: info@biogazelle.com
phone: +32 9 245 96 43
fax: +32 9 251 56 56
